✦ LIBER ✦

A Multicenter Phase II Study of Docetaxel 60 mg/m2as First-Line Chemotherapy in Patients with Advanced or Recurrent Breast Cancer

✍ Scribed by Takashi Ishikawa; Satoru Shimizu; Masaaki Inaba; Taro Asaga; Kiyohumi Katayama; Mamoru Fukuda; Yutaka Tokuda; Kazuo Ishida; Eisuke Fukuma; Takashi Suda; Yohei Hamaguchi; Akira Ishiyama; Hiroshi Shimada; Kanagawa Breast Cancer Treatment Society (KBCTS)

Publisher: Springer Japan
Year: 2004
Tongue: English
Weight: 554 KB
Volume: 11
Category: Article
ISSN: 1340-6868
DOI: 10.1007/bf02968045

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel and cisplatin in patients with

Docetaxel and cisplatin in patients with advanced or recurrent gastric cancer: a multicenter phase I/II study

✍ Yashushi Mitachi; Yuh Sakata; Atsushi Ohtsu; Ichinosuke Hyodo; Kenichi Katsu; Mo 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 85 KB

Results of a phase II study of pemetrexe

Results of a phase II study of pemetrexed as first-line chemotherapy in patients with advanced or metastatic breast cancer

✍ Nicholas J. Robert; Paul R. Conkling; Mark A. O’Rourke; Paul R. Kuefler; Kristi 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 234 KB

Phase I study of docetaxel and cyclophos

Phase I study of docetaxel and cyclophosphamide in patients with advanced or recurrent breast cancer

✍ Tadao Shimizu; Kohji Enomoto; Shunsuke Haga; Mamoru Fukuda; Yuichi lino; Tadashi 📂 Article 📅 2003 🏛 Springer Japan 🌐 English ⚖ 776 KB

A phase II trial of docetaxel (Taxotere®

A phase II trial of docetaxel (Taxotere®) as second-line chemotherapy in patients with metastatic breast cancer

✍ Martina Baur; Allan T. van Oosterom; Véronique Diéras; Michele Tubiana-Hulin; R. 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 385 KB

Phase I/II study of a combination of doc

Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer

✍ Yoon-Koo Kang; Min-Hee Ryu; Changhoon Yoo; Heung-Moon Chang; Jeong Hwan Yook; Su 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 334 KB

Gemcitabine plus docetaxel as first-line

Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: a lung cancer Galician group phase II study

✍ Joaquín Casal; Margarita Amenedo; José Ramón Mel; Luis Miguel Antón; Rubén Rodrí 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 343 KB